ARCHIVES

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 18 | May 14, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Program Announcements n Animal Retroviruses, Other Topics, Approved

March 30, 1990

Komen Foundation Breast Cancer Awards

April 15, 1994

CCOP Applications Total 162; Three Committees, Headed By Ahmann, Loeb, Spur Will Review Them

November 19, 1982

House Disallows NCI Recision

March 14, 1975

A Special Report: Language With A Purpose–von Eschenbach’s Four Years at NCI.

May 19, 2006